16- (2'- O- glucopyranosylglucopyranosyloxy)hexadecanoic acid 1',4''-lactone 6',6''-diacetate

Subscribe to Selected New Research on 16-(2'-O-glucopyranosylglucopyranosyloxy)hexadecanoic acid 1',4''-lactone 6',6''-diacetate

1 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: from Torulopsis apicola; structure given in first source

Also Known As:

16-(2'-O-beta-D-glucopyranosyl-beta-D-glucopyranosyloxy)hexadecanoic acid 1',4''-lactone-6',6''-diacetate; 16-GGHLD; lactonic sophorolipid

Bio-Agent Context: Research Results

Carbohydrates: 2945

Glycoconjugates: 631

Glycolipids: 722

16-(2'-O-glucopyranosylglucopyranosyloxy)hexadecanoic acid 1',4''-lactone 6',6''-diacetate: 1

Lipids: 13315

Glycolipids: 722

16-(2'-O-glucopyranosylglucopyranosyloxy)hexadecanoic acid 1',4''-lactone 6',6''-diacetate: 1

Related Diseases

1.	Necrosis 07/01/2008 - "MATERIALS AND METHODS: Human pancreatic carcinoma cells were treated with increasing concentrations of sophorolipid natural mixture or select derivatives (ethyl ester, methyl ester, ethyl ester monoacetate, ethyl ester diacetate, acidic sophorolipid [AS], lactonic sophorolipid diacetate [LSD]) for 24 h and assessed for cell necrosis (cytotoxicity-lactate dehydrogenase release)" Get all the results and reference details, order at left...
2.	Carcinoma (Carcinomatosis) 07/01/2008 - "MATERIALS AND METHODS: Human pancreatic carcinoma cells were treated with increasing concentrations of sophorolipid natural mixture or select derivatives (ethyl ester, methyl ester, ethyl ester monoacetate, ethyl ester diacetate, acidic sophorolipid [AS], lactonic sophorolipid diacetate [LSD]) for 24 h and assessed for cell necrosis (cytotoxicity-lactate dehydrogenase release)" Get all the results and reference details, order at left...
2 Diseases and 1 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Lysergic Acid Diethylamide (LSD)
2.	L-Lactate Dehydrogenase (Lactate Dehydrogenase)
2 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>